Market Overview

Benzinga's Top Pre-Market Losers

Share:
Related IPXL
FTC Requires Divestitures in Connection With Impax Laboratories Inc.'s Proposed Acquisition of CorePharma, LLC
JPM Securities Picks Through Biotech News For Winners
Related JCP
Deutsche Bank Is Talking Troubled Retailers And REIT Risk
Analyst Highlights The 'Scary Mall Owner Monopoly'
J.C. Penney Looks To Be Almost Out Of The Woods (Seeking Alpha)

Impax Laboratories (NASDAQ: IPXL) dipped 21.00% to $15.80 in the pre-market session. Impax Laboratories reported that the FDA completed its re-inspection of its Hayward manufacturing facility. At the conclusion of this inspection, the FDA issued a new Form 483 with 12 observations.

Hospira (NYSE: HSP) shares dropped 4.10% to $28.55 in pre-market trading. Hospira's trailing-twelve-month ROE is 1.48%.

J.C. Penney Co (NYSE: JCP) shares fell 3.82% to $16.10 in the pre-market trading on reports that a stakeholder is selling a large block of shares in the retailer.

Weyerhaeuser Co (NYSE: WY) dipped 3.17% to $29.00 in the pre-market session. Weyerhaeuser's PEG ratio is 5.65.

Posted-In: Top Pre-Market LosersNews Movers & Shakers Pre-Market Outlook Markets

 

Related Articles (IPXL + HSP)

Around the Web, We're Loving...